Active Not RecruitingNCT02808533
Topiramate added to clozapine for weight and symptoms in schizophrenia
About this title
Read the official source — NCT02808533Medication studyAges 17–59Canada
Understand this study
Who could participate?
Listed age limits: 17 years to 59 years.
- Listed locations
- TorontoSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 2016
- Recruitment status
- Active Not Recruiting
- Enrollment listed in the registry
- 50
- Sponsor
- Centre for Addiction and Mental Health
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug, Other
- Locations
- Canada
- Age range
- From 17 Years to 59 Years
- Official registry ID
- NCT02808533
- Official title
Show the full official title
Topiramate in Treatment Refractory Psychotic Illness: Effects on Weight Gain and Psychopathology
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Toronto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Topiramate.
Who can participate?
Listed age limits: 17 years to 59 years.
Is this study still recruiting?
The registry lists this study as active, but no longer recruiting.
